Kliniken & Institute ... Kliniken Zentrum für Innere... Innere Medizin V:... Forschung Forschungsbereich Zell-... AG Zelluläre... Publikationen

5 wichtigste Publikationen Prof. M. Schmitt

  1. Schmitt M, Schmitt A, Wiesneth M, Hückelhoven A, Wu Z, Kuball J, Wang L, Schauwecker P, Hofmann S, Götz M, Michels B, Maccari B, Wuchter P, Eckstein V, Mertens T, Schnitzler P, Hartmut Döhner H, Ho AD, Bunjes DW, Dreger P, Schrezenmeier H, Greiner J. Peptide vaccination in the presence of adjuvants in patients after allogeneic stem cell transplantation with CD4+ T cell reconstitution elicits consistent CD8+ responses.  
    Theranostics 2017 Apr 10;7(6):1705-1718.
    IF 8,712, 12 citations
  2. Schmitt M, Publicover A, Orchard KH, Görlach M, Wang L, Schmitt A, Mani J, Tsirigotis P, Kuriakose R, Nagler A. Biosimilar G-CSF based mobilization of peripheral blood hematopoietic stem cells for autologous and allogeneic stem cell transplantation. Theranostics. 23;4(3):280-9, 2014
    IF 8,712, 36 citations
  3. Schmitt A, Tonn T, Busch DH, Grigoleit G, Einsele H, Odendahl M, Germeroth L, Ringhoffer M, Ringhoffer S, Wiesneth M, Greiner J, Michel D, Mertens T, Rojewski M, Marx M, von Harsdorf S, Döhner H, Seifried E, Bunjes D, Schmitt M. Adoptive transfer and selective reconstitution of streptamer-selected CMV-specific CD8+ T cells leads to virus clearance in patients after allo-PBSCT. Transfusion 51:591-599, 2011.
    IF 3.423, 183 citations
  4. Schmitt M, Schmitt A, Rojewski M, Chen J, Götz M, Heyduk M, Giannopoulos K, Ritter G, Gnjatic S, Guillaume P, Ringhoffer M, Schlenk R, Liebisch P, Bunjes D, Shiku H, Döhner H, Greiner J. RHAMM-R3 peptide vaccination in patients with acute myeloid leukemia, myelodysplastic syndrome and multiple myeloma elicits immunological and clinical responses. Blood 111:1357-1365, 2008.
    IF: 15,132, 191 citations
  5. Greiner J, Li L, Ringhoffer M, Barth T, Wiesneth M, Döhner H, and Schmitt M. Identification and characterization of epitopes of the receptor for hyaluronic acid mediated motility (RHAMM/CD168) recognized by CD8 positive T cells of HLA-A2 positive patients with acute myeloid leukemia. Blood 106:938-945, 2005
    IF 15,132       119 citations